Map Pharmaceuticals Shareholder Alert: Briscoe Law Firm and Powers Taylor, LLP Investigate Sale to Allergan, Inc.
January 23 2013 - 9:51AM
Business Wire
Former United States Securities and Exchange Commission attorney
Willie Briscoe and the securities litigation firm of Powers Taylor,
LLP are investigating the sale of Map Pharmaceuticals, Inc. (“Map”)
(NasdaqGS: MAPP) to Allergan, Inc. for shareholders. Under the
terms of the proposed deal valued at approximately $157 million,
Map shareholders will only receive $25 in cash for each share of
Map stock owned. The merger is expected to close in the first
quarter or early in the second quarter of 2013.
If you are an affected investor, and you want to learn more
about the lawsuit or join the action, please contact Willie Briscoe
at The Briscoe Law Firm, PLLC, (214) 239-4568, via email at
WBriscoe@TheBriscoeLawFirm.com or Zach Groover at Powers Taylor,
LLP, toll free (877) 728-9607, via e-mail at zach@powerstaylor.com.
There is no cost or fee to you.
The Map sale investigation centers on whether Map’s shareholders
are receiving adequate compensation for their shares in the buyout,
whether the transaction undervalues Map’s stock, and whether Map’s
board attempted to obtain the highest share price for all
shareholders prior to agreeing to the deal. According to
shareholder rights attorney Willie Briscoe, “due to the proposed
sale price, the size of the deal and other factors, we believe this
transaction may undervalue Map’s stock. Our proposed lawsuit will
seek to obtain the highest share price for all shareholders.”
The Briscoe Law Firm, PLLC is a full service business litigation
and shareholder rights advocacy firm with more than 20 years of
experience in complex litigation and transactional matters.
Powers Taylor, LLP is a boutique litigation law firm that
handles a variety of complex business litigation matters, including
claims of investor and stockholder fraud, shareholder oppression,
shareholder derivative suits, and security class actions.
Map Pharmaceuticals, Inc. (MM) (NASDAQ:MAPP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Map Pharmaceuticals, Inc. (MM) (NASDAQ:MAPP)
Historical Stock Chart
From Jul 2023 to Jul 2024
